Navinta III Inc.
FDA 503B outsourcing facility
Boca Raton, Florida
Key Takeaways
- FDA-registered 503B outsourcing facility since 2026
- Sterile compounding from bulk substances: Yes
- Not yet inspected by the FDA
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- February 6, 2026
- Most recent registration
- February 6, 2026
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- Not yet inspected
Navinta III Inc. has registered with the FDA as a 503B outsourcing facility but has not yet been inspected. The FDA inspects registered facilities on a risk-based schedule once drug production and distribution are confirmed.
Compounded peptides and GLP-1s
Navinta III Inc. has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Location
1003 Clint Moore Rd, Boca Raton, FL 33487
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Mahendra Patel, 1-561-997-6595. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Navinta III Inc. with the Florida Board of Pharmacy.
503B facilities in Florida
Florida has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Florida.
Frequently asked questions
Is Navinta III Inc. registered with the FDA?
Yes. Navinta III Inc. is a registered 503B outsourcing facility, first registered with the FDA on February 6, 2026 and most recently registered on February 6, 2026.
Has Navinta III Inc. been inspected by the FDA?
Navinta III Inc. has registered with the FDA but has not yet been inspected as a 503B outsourcing facility.
Has Navinta III Inc. had any FDA drug recalls?
No FDA drug recalls are matched to Navinta III Inc. in the openFDA enforcement database.
What does Navinta III Inc. compound?
Navinta III Inc. has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is Navinta III Inc. located?
Navinta III Inc. is located in Boca Raton, Florida (1003 Clint Moore Rd).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Navinta III Inc.. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.